PROM1 and acute myeloid leukemia: AC133+ (a glycosylation-dependent epitope of CD133) cells from AML patients exhibited significantly elevated expression of WNT10B compared to normal AC133+ cells, which contain a glycosylation-specific site on CD133 that identifies stem and progenitor cells.